Neurovirulent factor ICP34.5 uniquely expressed in the herpes simplex virus type 1 Δ γ₁34.5 mutant 1716

References

• Ackermann M, Chou J, Sarmiento M, Lerner R A, Roizman B. Identification by antibody to a synthetic peptide of a protein specified by a diploid gene located in the terminal repeats of the L component of herpes simplex virus genome. J Virol 1986; 58: 843–850
   PubMed Web of Science ®Google Scholar
• Black T L, Barber G N, Katze M G. Degradation of the interferon-induced 68,000-M(r) protein kinase by poliovirus requires RNA. J Virol 1993; 67: 791–800
   PubMed Web of Science ®Google Scholar
• Bolovan C A, Sawtell N M, Thompson R L. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J Virol 1994; 68: 48–55
   Google Scholar
• Brown S M, Harland J, MacLean A R, Podlech J, Clements J B. Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2. J Gen Virol 1994; 75: 2367–2377, (Pt 9)
   Google Scholar
• Brown S M, MacLean A R, McKie E A, Harland J. The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34. J Virol 1997; 71: 9442–9449
   PubMed Web of Science ®Google Scholar
• Carroll K, Elroy-Stein O, Moss B, Jagus R. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. J Biol Chem 1993; 268: 12837–12842
   PubMed Web of Science ®Google Scholar
• Chou J, Kern E R, Whitley R J, Roizman B. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 1990; 250: 1262–1266
   PubMed Web of Science ®Google Scholar
• Chou J, Roizman B. The terminal a sequence of the herpes simplex virus genome contains the promoter of a gene located in the repeat sequences of the L component. J Virol 1986; 57: 629–637
   Google Scholar
• Chou J, Roizman B. The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells. Proc Natl Acad Sci U S A 1992; 89: 3266–3270
   PubMed Web of Science ®Google Scholar
• Chung R Y, Saeki Y, Chiocca E A. B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells. J Virol 1999; 73: 7556–7564
   PubMed Web of Science ®Google Scholar
• Davies M V, Chang H W, Jacobs B L, Kaufman R J. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J Virol 1993; 67: 1688–1692
   PubMed Web of Science ®Google Scholar
• He B, Chou J, Liebermann D A, Hoffman B, Roizman B. The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J Virol 1996; 70: 84–90
   PubMed Web of Science ®Google Scholar
• He B, Gross M, Roizman B. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A 1997; 94: 843–848
   PubMed Web of Science ®Google Scholar
• Jing X, He B. Characterization of the triplet repeats in the central domain of the gamma134.5 protein of herpes simplex virus 1. J Gen Virol 2005; 86: 2411–2419
   Google Scholar
• Katze M G. Regulation of the interferon-induced PKR: can viruses cope?. Trends Microbiol 1995; 3: 75–78
   PubMedGoogle Scholar
• Lee T G, Tang N, Thompson S, Miller J, Katze M G. The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol Cell Biol 1994; 14: 2331–2342
   PubMedGoogle Scholar
• Lu Y, Wambach M, Katze M G, Krug R M. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 1995; 214: 222–228
   PubMed Web of Science ®Google Scholar
• MacLean A R, ul-Fareed M, Robertson L, Harland J, Brown S M. Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the ‘a’ sequence. J Gen Virol 1991a; 72: 631–639, (Pt 3)
   PubMed Web of Science ®Google Scholar
• MacLean C A, Efstathiou S, Elliott M L, Jamieson F E, McGeoch D J. Investigation of herpes simplex virus type 1 genes encoding multiply inserted membrane proteins. J Gen Virol 1991b; 72: 897–906, (Pt 4)
   PubMedGoogle Scholar
• Mao H, Rosenthal K S. Strain-dependent structural variants of herpes simplex virus type 1 ICP34.5 determine viral plaque size, efficiency of glycoprotein processing, and viral release and neuroinvasive disease potential. J Virol 2003; 77: 3409–3417
   Google Scholar
• Markert J M, Medlock M D, Rabkin S D, Gillespie G Y, Todo T, Hunter W D, Palmer C A, Feigenbaum F, Tornatore C, Tufaro F, Martuza R L. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther 2000; 7: 867–874
   PubMed Web of Science ®Google Scholar
• Mathews M B, Shenk T. Adenovirus virus-associated RNA and translation control. J Virol 1991; 65: 5657–5662
   PubMed Web of Science ®Google Scholar
• McGeoch D J, Barnett B C. Neurovirulence factor. Nature 1991; 353: 609
   PubMedGoogle Scholar
• McGregor A, Roberts A, Davies R W, Clements J B, MacLean A R. Rapid generation of recombinant herpes simplex virus vectors expressing bacterial lacZ gene under-control of neuronal promoters. Gene Ther Mol Biol 1999; 4: 193–202
   Google Scholar
• McKay E M, McVey B, Marsden H S, Brown S M, MacLean A R. The herpes simplex virus type 1 strain 17 open reading frame RL1 encodes a polypeptide of apparent M(r) 37K equivalent to ICP34.5 of herpes simplex virus type 1 strain F. J Gen Virol 1993; 74: 2493–2497, (Pt 11)
   Google Scholar
• McKie E A, Brown S M, MacLean A R, Graham D I. Histopathological responses in the CNS following inoculation with a non-neurovirulent mutant (1716) of herpes simplex virus type 1 (HSV 1): relevance for gene and cancer therapy. Neuropathol Appl Neurobiol 1998a; 24: 367–372
   Google Scholar
• McKie E A, Graham D I, Brown S M. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector—potential glioblastoma targeting. Gene Ther 1998b; 5: 440–450
   Google Scholar
• McKie E A, Hope R G, Brown S M, MacLean A R. Characterization of the herpes simplex virus type 1 strain 17+ neurovirulence gene RL1 and its expression in a bacterial system. J Gen Virol 1994; 75: 733–741, (Pt 4)
   Google Scholar
• McKie E A, MacLean A R, Lewis A D, Cruickshank G, Rampling R, Barnett S C, Kennedy P G, Brown S M. Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours—evaluation of a potentially effective clinical therapy. Br J Cancer 1996; 74: 745–752
   PubMed Web of Science ®Google Scholar
• Mohr I, Gluzman Y. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J 1996; 15: 4759–4766
   PubMed Web of Science ®Google Scholar
• Rampling R, Cruickshank G, Papanastassiou V, Nicoll J, Hadley D, Brennan D, Petty R, MacLean A, Harland J, McKie E, Mabbs R, Brown M. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther 2000; 7: 859–866
   PubMed Web of Science ®Google Scholar
• Sawtell N M. Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation. J Virol 2003; 77: 4127–4138
   PubMed Web of Science ®Google Scholar
• Thompson R L, Wagner E K, Stevens J G. Physical location of a herpes simplex virus type-1 gene function(s) specifically associated with a 10 million-fold increase in HSV neurovirulence. Virology 1983; 131: 180–192
   PubMedGoogle Scholar
• Ward S L, Scheuner D, Poppers J, Kaufman R J, Mohr I, Leib D A. In vivo replication of an ICP34.5 second-site suppressor mutant following corneal infection correlates with in vitro regulation of eIF2 alpha phosphorylation. J Virol 2003; 77: 4626–4634
   Google Scholar